Search Results for "Butal Acet Caff 50 325 40mg"

23:50 EDT 3rd September 2015 | BioPortfolio

Matching Channels

None

Matching News

Pfizer teams with Synthon on generic Copaxone

Synthon has filed an application for a generic version of Teva's improved 40mg/mL dosage of the multiple sclerosis drug.

US Patent Board To Review Mylan's Copaxone Challenge

The PTAB said there is a "reasonable likelihood" Mylan would prevail in its challenges against Teva's patents, known as '250 and '413, which cover the Israeli firm's 40mg/mL three-times per week dosag...

Frusol administration update

Frusol (furosemide; Rosemont Pharmaceuticals) oral solutions 20mg/5ml, 40mg/5ml and 50mg/5ml have been approved for administration via nasogastric (NG) or percutaneous endoscopic gastrostomy (PEG) tub...

FDA approves Cipla’s Lopinavir/ritonavir for AIDS in infants and young children

Cipla, a global pharmaceutical company, has received FDA approval for Lopinavir/ritonavir (LPV/r) 40mg/10mg oral pellets for paediatric specific treatment for infants.

Neurocrine Announces Completion of Enrollment into Kinect 3 Tardive Dyskinesia Study

SAN DIEGO, Aug. 13, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has recently completed subject randomization of the Phase III clinical ...

DelMar Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference on September 9, 2015

VANCOUVER, British Columbia and MENLO PARK, Calif., Aug. 25, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on t...

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

Synthon’s glatiramer acetate, a potential generic version of Copaxone®1 for the treatment of relapsing remitting multiple sclerosis is currently being reviewed by the U....

DelMar Pharmaceuticals Receives Additional Non-Dilutive Funding from NRC-IRAP to Support Expanded Research Program with Lead Product Candidate VAL-083

VANCOUVER, British Columbia and MENLO PARK, Calif., Aug. 17, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on d...

Matching PubMed Articles

Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells.

There is an increasing prevalence of Alzheimer's disease (AD), which has become a public health issue. However, the underlying mechanisms for the pathogenesis of AD are not fully understood, and the c...

Numerical simulation on the opto-electro-kinetic patterning for rapid concentration of particles in a microchannel.

This paper presents a mathematical model for laser-induced rapid electro-kinetic patterning (REP) to elucidate the mechanism for concentrating particles in a microchannel non-destructively and non-inv...

Crystal structure of 1-(2-chloro-acet-yl)-3,3-dimethyl-2,6-di-p-tolyl-piperidin-4-one.

In the title compound, C23H26ClNO2, the piperidin-4-one ring adopts a distorted boat conformation. The two p-tolyl rings are nearly normal to each other, making a dihedral angle of 83.33 (10)°. The...

Carbohydrate mouth rinse and caffeine improves high-intensity interval running capacity when carbohydrate restricted.

We tested the hypothesis that carbohydrate mouth rinsing, alone or in combination with caffeine, augments high-intensity interval (HIT) running capacity undertaken in a carbohydrate-restricted state. ...

Crystal structure of (3S)-3-acet-oxy-17-(pyridin-3-yl)androsta-5,16-diene.

In the title compound, C26H33NO2 [systematic name: (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodeca-hydro-1H-cyclo-penta-[a]phenanthren-3-yl acetate], the s...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement